English
简体中文
Total: £ 56.28
Published Date: 2025-05-02 | Pages: 100 | Tables: 102 | Pharma & Healthcare
The global market for Antibody was valued at US$ 10070 million in the year 2024 and is projected to reach a revised size of US$ 14390 million by 2031, growing at a CAGR of 5.3% during the forecast period.
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Global Monoclonal Antibodies key players include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.
In terms of product, IgG is the largest segment, with a share about 80%. And in terms of application, the largest application is Research, followed by Therapeutic and Diagnostic.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody.
The Antibody market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Roche
Johnson and Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Segment by Type
IgM
IgG
IgA
Other
Segment by Application
Therapeutic
Research
Diagnostic
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Antibody Market Overview
1.1 Product Definition
1.2 Antibody by Type
1.2.1 Global Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 IgM
1.2.3 IgG
1.2.4 IgA
1.2.5 Other
1.3 Antibody by Application
1.3.1 Global Antibody Market Value by Application (2024 VS 2031)
1.3.2 Therapeutic
1.3.3 Research
1.3.4 Diagnostic
1.4 Global Antibody Market Size Estimates and Forecasts
1.4.1 Global Antibody Revenue 2020-2031
1.4.2 Global Antibody Sales 2020-2031
1.4.3 Global Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Antibody Market Competition by Manufacturers
2.1 Global Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antibody, Product Type & Application
2.7 Global Key Manufacturers of Antibody, Date of Enter into This Industry
2.8 Global Antibody Market Competitive Situation and Trends
2.8.1 Global Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antibody Players Market Share by Revenue
2.8.3 Global Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antibody Market Scenario by Region
3.1 Global Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Antibody Sales by Region: 2020-2031
3.2.1 Global Antibody Sales by Region: 2020-2025
3.2.2 Global Antibody Sales by Region: 2026-2031
3.3 Global Antibody Revenue by Region: 2020-2031
3.3.1 Global Antibody Revenue by Region: 2020-2025
3.3.2 Global Antibody Revenue by Region: 2026-2031
3.4 North America Antibody Market Facts & Figures by Country
3.4.1 North America Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Antibody Sales by Country (2020-2031)
3.4.3 North America Antibody Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antibody Market Facts & Figures by Country
3.5.1 Europe Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Antibody Sales by Country (2020-2031)
3.5.3 Europe Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Antibody Market Facts & Figures by Country
3.7.1 Latin America Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Antibody Sales by Country (2020-2031)
3.7.3 Latin America Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antibody Sales by Type (2020-2031)
4.1.1 Global Antibody Sales by Type (2020-2025)
4.1.2 Global Antibody Sales by Type (2026-2031)
4.1.3 Global Antibody Sales Market Share by Type (2020-2031)
4.2 Global Antibody Revenue by Type (2020-2031)
4.2.1 Global Antibody Revenue by Type (2020-2025)
4.2.2 Global Antibody Revenue by Type (2026-2031)
4.2.3 Global Antibody Revenue Market Share by Type (2020-2031)
4.3 Global Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global Antibody Sales by Application (2020-2031)
5.1.1 Global Antibody Sales by Application (2020-2025)
5.1.2 Global Antibody Sales by Application (2026-2031)
5.1.3 Global Antibody Sales Market Share by Application (2020-2031)
5.2 Global Antibody Revenue by Application (2020-2031)
5.2.1 Global Antibody Revenue by Application (2020-2025)
5.2.2 Global Antibody Revenue by Application (2026-2031)
5.2.3 Global Antibody Revenue Market Share by Application (2020-2031)
5.3 Global Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Antibody Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Johnson and Johnson
6.2.1 Johnson and Johnson Company Information
6.2.2 Johnson and Johnson Description and Business Overview
6.2.3 Johnson and Johnson Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Johnson and Johnson Antibody Product Portfolio
6.2.5 Johnson and Johnson Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Antibody Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Antibody Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 AbbVie
6.5.1 AbbVie Company Information
6.5.2 AbbVie Description and Business Overview
6.5.3 AbbVie Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AbbVie Antibody Product Portfolio
6.5.5 AbbVie Recent Developments/Updates
6.6 Amgen
6.6.1 Amgen Company Information
6.6.2 Amgen Description and Business Overview
6.6.3 Amgen Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Amgen Antibody Product Portfolio
6.6.5 Amgen Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Pfizer Antibody Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Bayer
6.8.1 Bayer Company Information
6.8.2 Bayer Description and Business Overview
6.8.3 Bayer Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bayer Antibody Product Portfolio
6.8.5 Bayer Recent Developments/Updates
6.9 Lilly
6.9.1 Lilly Company Information
6.9.2 Lilly Description and Business Overview
6.9.3 Lilly Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Lilly Antibody Product Portfolio
6.9.5 Lilly Recent Developments/Updates
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Company Information
6.10.2 Bristol-Myers Squibb Description and Business Overview
6.10.3 Bristol-Myers Squibb Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bristol-Myers Squibb Antibody Product Portfolio
6.10.5 Bristol-Myers Squibb Recent Developments/Updates
6.11 GlaxoSmithKline
6.11.1 GlaxoSmithKline Company Information
6.11.2 GlaxoSmithKline Description and Business Overview
6.11.3 GlaxoSmithKline Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 GlaxoSmithKline Antibody Product Portfolio
6.11.5 GlaxoSmithKline Recent Developments/Updates
6.12 Biogen
6.12.1 Biogen Company Information
6.12.2 Biogen Description and Business Overview
6.12.3 Biogen Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Biogen Antibody Product Portfolio
6.12.5 Biogen Recent Developments/Updates
6.13 AstraZeneca
6.13.1 AstraZeneca Company Information
6.13.2 AstraZeneca Description and Business Overview
6.13.3 AstraZeneca Antibody Sales, Revenue and Gross Margin (2020-2025)
6.13.4 AstraZeneca Antibody Product Portfolio
6.13.5 AstraZeneca Recent Developments/Updates
6.14 Sanofi
6.14.1 Sanofi Company Information
6.14.2 Sanofi Description and Business Overview
6.14.3 Sanofi Antibody Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sanofi Antibody Product Portfolio
6.14.5 Sanofi Recent Developments/Updates
6.15 Alexion Pharmaceuticals
6.15.1 Alexion Pharmaceuticals Company Information
6.15.2 Alexion Pharmaceuticals Description and Business Overview
6.15.3 Alexion Pharmaceuticals Antibody Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Alexion Pharmaceuticals Antibody Product Portfolio
6.15.5 Alexion Pharmaceuticals Recent Developments/Updates
6.16 Seattle Genetics
6.16.1 Seattle Genetics Company Information
6.16.2 Seattle Genetics Description and Business Overview
6.16.3 Seattle Genetics Antibody Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Seattle Genetics Antibody Product Portfolio
6.16.5 Seattle Genetics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antibody Industry Chain Analysis
7.2 Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antibody Production Mode & Process Analysis
7.4 Antibody Sales and Marketing
7.4.1 Antibody Sales Channels
7.4.2 Antibody Distributors
7.5 Antibody Customer Analysis
8 Antibody Market Dynamics
8.1 Antibody Industry Trends
8.2 Antibody Market Drivers
8.3 Antibody Market Challenges
8.4 Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Antibody Market Competitive Situation by Manufacturers in 2024
Table 4. Global Antibody Sales (KG) of Key Manufacturers (2020-2025)
Table 5. Global Antibody Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Antibody Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Antibody Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Antibody, Product Type & Application
Table 12. Global Key Manufacturers of Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Antibody Sales by Region (2020-2025) & (KG)
Table 18. Global Antibody Sales Market Share by Region (2020-2025)
Table 19. Global Antibody Sales by Region (2026-2031) & (KG)
Table 20. Global Antibody Sales Market Share by Region (2026-2031)
Table 21. Global Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Antibody Revenue Market Share by Region (2020-2025)
Table 23. Global Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Antibody Revenue Market Share by Region (2026-2031)
Table 25. North America Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Antibody Sales by Country (2020-2025) & (KG)
Table 27. North America Antibody Sales by Country (2026-2031) & (KG)
Table 28. North America Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Antibody Sales by Country (2020-2025) & (KG)
Table 32. Europe Antibody Sales by Country (2026-2031) & (KG)
Table 33. Europe Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Antibody Sales by Region (2020-2025) & (KG)
Table 37. Asia Pacific Antibody Sales by Region (2026-2031) & (KG)
Table 38. Asia Pacific Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Antibody Sales by Country (2020-2025) & (KG)
Table 42. Latin America Antibody Sales by Country (2026-2031) & (KG)
Table 43. Latin America Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Antibody Sales by Country (2020-2025) & (KG)
Table 47. Middle East and Africa Antibody Sales by Country (2026-2031) & (KG)
Table 48. Middle East and Africa Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Antibody Sales (KG) by Type (2020-2025)
Table 51. Global Antibody Sales (KG) by Type (2026-2031)
Table 52. Global Antibody Sales Market Share by Type (2020-2025)
Table 53. Global Antibody Sales Market Share by Type (2026-2031)
Table 54. Global Antibody Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Antibody Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Antibody Revenue Market Share by Type (2020-2025)
Table 57. Global Antibody Revenue Market Share by Type (2026-2031)
Table 58. Global Antibody Price (USD/KG) by Type (2020-2025)
Table 59. Global Antibody Price (USD/KG) by Type (2026-2031)
Table 60. Global Antibody Sales (KG) by Application (2020-2025)
Table 61. Global Antibody Sales (KG) by Application (2026-2031)
Table 62. Global Antibody Sales Market Share by Application (2020-2025)
Table 63. Global Antibody Sales Market Share by Application (2026-2031)
Table 64. Global Antibody Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Antibody Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Antibody Revenue Market Share by Application (2020-2025)
Table 67. Global Antibody Revenue Market Share by Application (2026-2031)
Table 68. Global Antibody Price (USD/KG) by Application (2020-2025)
Table 69. Global Antibody Price (USD/KG) by Application (2026-2031)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 73. Roche Antibody Product
Table 74. Roche Recent Developments/Updates
Table 75. Johnson and Johnson Company Information
Table 76. Johnson and Johnson Description and Business Overview
Table 77. Johnson and Johnson Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 78. Johnson and Johnson Antibody Product
Table 79. Johnson and Johnson Recent Developments/Updates
Table 80. Merck Company Information
Table 81. Merck Description and Business Overview
Table 82. Merck Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Merck Antibody Product
Table 84. Merck Recent Developments/Updates
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Novartis Antibody Product
Table 89. Novartis Recent Developments/Updates
Table 90. AbbVie Company Information
Table 91. AbbVie Description and Business Overview
Table 92. AbbVie Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. AbbVie Antibody Product
Table 94. AbbVie Recent Developments/Updates
Table 95. Amgen Company Information
Table 96. Amgen Description and Business Overview
Table 97. Amgen Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Amgen Antibody Product
Table 99. Amgen Recent Developments/Updates
Table 100. Pfizer Company Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Pfizer Antibody Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Bayer Company Information
Table 106. Bayer Description and Business Overview
Table 107. Bayer Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Bayer Antibody Product
Table 109. Bayer Recent Developments/Updates
Table 110. Lilly Company Information
Table 111. Lilly Description and Business Overview
Table 112. Lilly Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Lilly Antibody Product
Table 114. Lilly Recent Developments/Updates
Table 115. Bristol-Myers Squibb Company Information
Table 116. Bristol-Myers Squibb Description and Business Overview
Table 117. Bristol-Myers Squibb Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Bristol-Myers Squibb Antibody Product
Table 119. Bristol-Myers Squibb Recent Developments/Updates
Table 120. GlaxoSmithKline Company Information
Table 121. GlaxoSmithKline Description and Business Overview
Table 122. GlaxoSmithKline Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. GlaxoSmithKline Antibody Product
Table 124. GlaxoSmithKline Recent Developments/Updates
Table 125. Biogen Company Information
Table 126. Biogen Description and Business Overview
Table 127. Biogen Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Biogen Antibody Product
Table 129. Biogen Recent Developments/Updates
Table 130. AstraZeneca Company Information
Table 131. AstraZeneca Description and Business Overview
Table 132. AstraZeneca Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. AstraZeneca Antibody Product
Table 134. AstraZeneca Recent Developments/Updates
Table 135. Sanofi Company Information
Table 136. Sanofi Description and Business Overview
Table 137. Sanofi Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Sanofi Antibody Product
Table 139. Sanofi Recent Developments/Updates
Table 140. Alexion Pharmaceuticals Company Information
Table 141. Alexion Pharmaceuticals Description and Business Overview
Table 142. Alexion Pharmaceuticals Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Alexion Pharmaceuticals Antibody Product
Table 144. Alexion Pharmaceuticals Recent Developments/Updates
Table 145. Seattle Genetics Company Information
Table 146. Seattle Genetics Description and Business Overview
Table 147. Seattle Genetics Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Seattle Genetics Antibody Product
Table 149. Seattle Genetics Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Antibody Distributors List
Table 153. Antibody Customers List
Table 154. Antibody Market Trends
Table 155. Antibody Market Drivers
Table 156. Antibody Market Challenges
Table 157. Antibody Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Antibody
Figure 2. Global Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antibody Market Share by Type: 2024 & 2031
Figure 4. IgM Product Picture
Figure 5. IgG Product Picture
Figure 6. IgA Product Picture
Figure 7. Other Product Picture
Figure 8. Global Antibody Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Antibody Market Share by Application: 2024 & 2031
Figure 10. Therapeutic
Figure 11. Research
Figure 12. Diagnostic
Figure 13. Global Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Antibody Market Size (2020-2031) & (US$ Million)
Figure 15. Global Antibody Sales (2020-2031) & (KG)
Figure 16. Global Antibody Average Price (USD/KG) & (2020-2031)
Figure 17. Antibody Report Years Considered
Figure 18. Antibody Sales Share by Manufacturers in 2024
Figure 19. Global Antibody Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Antibody Players: Market Share by Revenue in Antibody in 2024
Figure 21. Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Antibody Sales Market Share by Country (2020-2031)
Figure 24. North America Antibody Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Antibody Sales Market Share by Country (2020-2031)
Figure 28. Europe Antibody Revenue Market Share by Country (2020-2031)
Figure 29. Germany Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Antibody Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Antibody Revenue Market Share by Region (2020-2031)
Figure 36. China Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Antibody Sales Market Share by Country (2020-2031)
Figure 46. Latin America Antibody Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Antibody Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Antibody Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Antibody by Type (2020-2031)
Figure 56. Global Revenue Market Share of Antibody by Type (2020-2031)
Figure 57. Global Antibody Price (USD/KG) by Type (2020-2031)
Figure 58. Global Sales Market Share of Antibody by Application (2020-2031)
Figure 59. Global Revenue Market Share of Antibody by Application (2020-2031)
Figure 60. Global Antibody Price (USD/KG) by Application (2020-2031)
Figure 61. Antibody Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
